Loading…
No business profile yet.
Size Q & M Dental Group (Singapore) (QC7.SI) is a Singapore Health Care company (Hospital/Nursing Management) with a market value of $353M, the 129th largest of 186 Singapore companies the cockpit tracks. Shares closed at S$0.48 on 6 Nov 2026.
Performance Over six months the shares fell 17.9%, against -2.2% for the median peer and -1.2% for the Singapore market (cap-weighted) — 7th lowest of 20 in its peer set.
Growth Revenue grew 15.8% over the last twelve months (peer median +10.9%); the operating margin is 9.0% (peer median 9.2%).
Valuation It trades at 34.5× forward earnings against a peer median of 20.9× (6th most expensive of 14).
Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 1.6 points above its cost of capital (5.2% WACC).
Next results Next results expected around 1 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | S$208M | S$197M | S$181M | S$183M | S$181M |
| Revenue growth | — | +9% | -1% | +1% | — |
| Gross profit | S$34.8M | S$38.6M | S$37.8M | S$36.6M | S$35.4M |
| EBITDA | S$40.1M | S$42.3M | S$41.5M | S$39.7M | S$36.0M |
| Net income | S$10.4M | S$9.31M | S$14.3M | S$11.5M | S$11.3M |
| Free cash flow | S$17.9M | S$27.8M | S$28.4M | S$23.6M | S$22.2M |
| Capital expenditure | S$11.8M | S$4.97M | S$8.11M | S$6.55M | S$11.0M |
| Total debt | n/a | S$188M | S$115M | S$130M | S$141M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | QC7.SI | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -8.6% | -0.7% | 5th lowest of 20 |
| 6-month return | -17.9% | -2.2% | 7th lowest of 20 |
| Distance from 52-week high | -24.4% | -22.6% | 9th lowest of 20 |
| Revenue growth (TTM) | +15.8% | +10.9% | 5th highest of 21 |
| Operating margin | 9.0% | 9.2% | 11th highest of 21 |
| Forward P/E | 34.5× | 20.9× | 6th most expensive of 14 |
| Growth the price implies (Req g, 7 yrs) | 8.2% | 4.0% | 6th most demanding of 15 |
| Growth delivered (Del g) | +7.5% | +15.5% | 4th lowest of 15 |
| Hurdle (Req g minus delivered) | +0.7 pp | -8.4 pp | 4th most demanding of 15 |
| ROIC minus cost of capital | +1.6 pp | +1.0 pp | 11th highest of 21 |
| EV / EBITDA | 13.6× | 10.0× | 9th most expensive of 19 |
| Net debt / EBITDA | 1.6× | 0.5× | 8th most indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Q & M Dental Group (Singapore) QC7.SI | Singapore | $353M | -18% | +16% | 9% | 34.5× | 8.2% | +7.5% |
| Viemed Healthcare VMD | United States | $348M | +2% | +25% | 8% | 18.1× | 6.2% | +15.5% |
| Liaoning He Eye Hospital 301103.SZ | China | $365M | -21% | +3% | 4% | n/a | -2.1% | +5.4% |
| Indraprastha Medical INDRAMEDCO.NS | India | $321M | -21% | +11% | 15% | 14.7× | 16.7% | +19.3% |
| Community Health Systems CYH | United States | $312M | -21% | -8% | 7% | n/a | n/a | n/a |
| Voxel VOX.WA | Poland | $405M | +50% | +14% | 24% | 13.7× | 1.1% | +12.2% |
| China Resources Medical 1515.HK | Hong Kong | $415M | -12% | 0% | 6% | 5.7× | -7.3% | +26.3% |
| Bright Eye Hospital 301239.SZ | China | $419M | -23% | +11% | 9% | 46.2× | -3.7% | +15.5% |
| MEDICLIN Aktiengesellschaft MED.DE | Germany | $285M | +48% | +3% | 8% | 6.8× | -9.1% | +3.5% |
| Bayzed Health 2609.HK | Hong Kong | $453M | -49% | -2% | 5% | n/a | 17.4% | +9.2% |
| Artemis Medicare Services ARTEMISMED.NS | India | $514M | +16% | +15% | 14% | 37.6× | 45.8% | +21.5% |
| Garofalo Health Care GHC.MI | Italy | $540M | +1% | +4% | 10% | 20.9× | 1.8% | +18.3% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $689M | +4% | +15% | 21% | n/a | 16.3% | +18.1% |
| Paras Healthcare PARASHLTH.NS | India | $844M | n/a | +24% | 11% | n/a | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $940M | -7% | +11% | 20% | 18.2× | 0.7% | +19.7% |
| HealthCare Global Enterprises HCG.NS | India | $950M | -2% | +14% | 8% | 67.3× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $953M | -21% | +6% | 10% | n/a | 20.9% | +11.8% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1,000M | +14% | +17% | 16% | 48.5× | n/a | n/a |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.05B | +25% | +50% | 16% | 41.0× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.08B | +14% | +5% | 3% | 22.5× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $1.09B | -15% | +3% | 4% | n/a | 6.3% | +6.0% |